Zhongzhu Medical Holdings Co Ltd (600568) - Net Assets

Latest as of March 2026: CN¥1.61 Billion CNY ≈ $235.40 Million USD

Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has net assets worth CN¥1.61 Billion CNY (≈ $235.40 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.95 Billion ≈ $285.43 Million USD) and total liabilities (CN¥341.90 Million ≈ $50.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is Zhongzhu Medical Holdings Co Ltd's balance sheet for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.61 Billion
% of Total Assets	82.47%
Annual Growth Rate	13.1%
5-Year Change	-56.26%
10-Year Change	-72.88%
Growth Volatility	85.84

Zhongzhu Medical Holdings Co Ltd - Net Assets Trend (1998–2025)

This chart illustrates how Zhongzhu Medical Holdings Co Ltd's net assets have evolved over time, based on quarterly financial data. Check 600568 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Zhongzhu Medical Holdings Co Ltd (1998–2025)

The table below shows the annual net assets of Zhongzhu Medical Holdings Co Ltd from 1998 to 2025. For live valuation and market cap data, see 600568 market cap.

Year	Net Assets	Change
2025-12-31	CN¥1.63 Billion ≈ $238.63 Million	-6.43%
2024-12-31	CN¥1.74 Billion ≈ $255.02 Million	-32.72%
2023-12-31	CN¥2.59 Billion ≈ $379.07 Million	-11.79%
2022-12-31	CN¥2.94 Billion ≈ $429.73 Million	-21.24%
2021-12-31	CN¥3.73 Billion ≈ $545.62 Million	-6.31%
2020-12-31	CN¥3.98 Billion ≈ $582.38 Million	+2.26%
2019-12-31	CN¥3.89 Billion ≈ $569.54 Million	-8.57%
2018-12-31	CN¥4.26 Billion ≈ $622.92 Million	-30.74%
2017-12-31	CN¥6.15 Billion ≈ $899.41 Million	+2.23%
2016-12-31	CN¥6.01 Billion ≈ $879.82 Million	+127.31%
2015-12-31	CN¥2.65 Billion ≈ $387.06 Million	+2.54%
2014-12-31	CN¥2.58 Billion ≈ $377.47 Million	+118.82%
2013-12-31	CN¥1.18 Billion ≈ $172.51 Million	+14.70%
2012-12-31	CN¥1.03 Billion ≈ $150.39 Million	+12.22%
2011-12-31	CN¥915.88 Million ≈ $134.02 Million	+23.31%
2010-12-31	CN¥742.77 Million ≈ $108.69 Million	+9.67%
2009-12-31	CN¥677.27 Million ≈ $99.11 Million	+9.90%
2008-12-31	CN¥616.24 Million ≈ $90.17 Million	+19.66%
2007-12-31	CN¥514.98 Million ≈ $75.36 Million	+7.46%
2006-12-31	CN¥479.24 Million ≈ $70.13 Million	-14.23%
2005-12-31	CN¥558.76 Million ≈ $81.76 Million	+14.15%
2004-12-31	CN¥489.48 Million ≈ $71.63 Million	+3.50%
2003-12-31	CN¥472.91 Million ≈ $69.20 Million	+6.35%
2002-12-31	CN¥444.66 Million ≈ $65.07 Million	+2.58%
2001-12-31	CN¥433.47 Million ≈ $63.43 Million	+426.29%
2000-12-31	CN¥82.36 Million ≈ $12.05 Million	+18.07%
1999-12-31	CN¥69.76 Million ≈ $10.21 Million	+18.87%
1998-12-31	CN¥58.68 Million ≈ $8.59 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Zhongzhu Medical Holdings Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 24881.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	CN¥5.02 Billion	306.55%
Total Equity	CN¥1.64 Billion	100.00%

Zhongzhu Medical Holdings Co Ltd Competitors by Market Cap

The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their market capitalization.

Company	Market Cap
Cognyte Software Ltd NASDAQ:CGNT	$656.26 Million
JINXIN FERT.GRP HD-00001 F:3NX	$656.44 Million
China Building Material SHG:603060	$656.46 Million
Chapters Group AG XETRA:CHG	$656.80 Million
Vitesse Energy Inc NYSE:VTS	$656.14 Million
Shenzhen Exc Led Technology Co Ltd SHE:300889	$656.12 Million
Beijing Beilu Pharmaceutical SHE:300016	$655.63 Million
Valor Estate Limited NSE:DBREALTY	$655.46 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhongzhu Medical Holdings Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,749,275,473 to 1,636,000,631, a change of -113,274,842 (-6.5%).
Net loss of 114,191,647 reduced equity.
Dividend payments of 32,959 reduced retained earnings.
Other comprehensive income decreased equity by 122,563,202.
Other factors increased equity by 123,512,966.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥-114.19 Million	-6.98%
Dividends Paid	CN¥32.96K	-0.0%
Other Comprehensive Income	CN¥-122.56 Million	-7.49%
Other Changes	CN¥123.51 Million	+7.55%
Total Change	CN¥-	-6.48%

Book Value vs Market Value Analysis

This analysis compares Zhongzhu Medical Holdings Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.74x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 27.84x to 2.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1998-12-31	CN¥0.08	CN¥2.25	x
1999-12-31	CN¥0.10	CN¥2.25	x
2000-12-31	CN¥0.11	CN¥2.25	x
2001-12-31	CN¥0.60	CN¥2.25	x
2002-12-31	CN¥0.61	CN¥2.25	x
2003-12-31	CN¥0.63	CN¥2.25	x
2004-12-31	CN¥0.65	CN¥2.25	x
2005-12-31	CN¥0.61	CN¥2.25	x
2006-12-31	CN¥0.49	CN¥2.25	x
2007-12-31	CN¥0.49	CN¥2.25	x
2008-12-31	CN¥0.41	CN¥2.25	x
2009-12-31	CN¥0.63	CN¥2.25	x
2010-12-31	CN¥0.71	CN¥2.25	x
2011-12-31	CN¥0.89	CN¥2.25	x
2012-12-31	CN¥0.94	CN¥2.25	x
2013-12-31	CN¥1.00	CN¥2.25	x
2014-12-31	CN¥2.32	CN¥2.25	x
2015-12-31	CN¥1.72	CN¥2.25	x
2016-12-31	CN¥3.24	CN¥2.25	x
2017-12-31	CN¥3.01	CN¥2.25	x
2018-12-31	CN¥2.03	CN¥2.25	x
2019-12-31	CN¥1.90	CN¥2.25	x
2020-12-31	CN¥1.89	CN¥2.25	x
2021-12-31	CN¥1.80	CN¥2.25	x
2022-12-31	CN¥1.40	CN¥2.25	x
2023-12-31	CN¥1.23	CN¥2.25	x
2024-12-31	CN¥0.89	CN¥2.25	x
2025-12-31	CN¥0.82	CN¥2.25	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhongzhu Medical Holdings Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -6.98%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -19.78%
• Asset Turnover: 0.29x
• Equity Multiplier: 1.21x
Recent ROE (-6.98%) is below the historical average (-1.09%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1998	16.29%	17.17%	0.53x	1.78x	CN¥3.69 Million
1999	15.88%	17.64%	0.55x	1.64x	CN¥4.10 Million
2000	15.31%	16.53%	0.57x	1.63x	CN¥4.37 Million
2001	3.20%	16.98%	0.18x	1.06x	CN¥-29.48 Million
2002	2.52%	12.33%	0.19x	1.08x	CN¥-33.28 Million
2003	2.53%	6.47%	0.31x	1.25x	CN¥-34.07 Million
2004	1.85%	1.94%	0.59x	1.63x	CN¥-38.62 Million
2005	-8.54%	-4.68%	0.59x	3.11x	CN¥-82.33 Million
2006	-24.30%	-5.85%	1.13x	3.67x	CN¥-122.27 Million
2007	5.01%	0.99%	1.40x	3.61x	CN¥-18.38 Million
2008	9.90%	1.65%	1.49x	4.01x	CN¥-422.47K
2009	22.78%	7.25%	1.41x	2.23x	CN¥82.22 Million
2010	10.12%	16.40%	0.21x	2.91x	CN¥877.83K
2011	20.07%	39.44%	0.22x	2.30x	CN¥91.86 Million
2012	6.22%	9.59%	0.28x	2.33x	CN¥-36.57 Million
2013	5.88%	7.67%	0.30x	2.56x	CN¥-42.42 Million
2014	1.36%	3.03%	0.24x	1.91x	CN¥-205.02 Million
2015	3.01%	7.96%	0.21x	1.76x	CN¥-170.34 Million
2016	5.02%	26.77%	0.15x	1.22x	CN¥-291.74 Million
2017	2.83%	17.26%	0.13x	1.21x	CN¥-429.55 Million
2018	-46.73%	-330.73%	0.10x	1.39x	CN¥-2.30 Billion
2019	-10.02%	-53.08%	0.15x	1.30x	CN¥-738.09 Million
2020	0.08%	0.44%	0.16x	1.19x	CN¥-376.39 Million
2021	-5.87%	-36.36%	0.13x	1.24x	CN¥-571.03 Million
2022	-28.57%	-157.97%	0.14x	1.33x	CN¥-1.08 Billion
2023	-14.02%	-53.86%	0.21x	1.23x	CN¥-589.34 Million
2024	-35.46%	-118.96%	0.25x	1.21x	CN¥-795.15 Million
2025	-6.98%	-19.78%	0.29x	1.21x	CN¥-277.79 Million

Industry Comparison

This section compares Zhongzhu Medical Holdings Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $2,133,881,544
Average return on equity (ROE) among peers: 2.68%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Zhongzhu Medical Holdings Co Ltd (600568)	CN¥1.61 Billion	16.29%	0.21x	$656.14 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$868.76 Million	4.89%	3.05x	$639.13 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$775.01 Million	2.45%	0.87x	$378.07 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$10.33 Billion	15.07%	0.27x	$5.07 Billion
Livzon Pharmaceutical Group Inc (000513)	$662.32 Million	12.10%	0.68x	$2.59 Billion
Wedge Industrial Co Ltd (000534)	$692.08 Million	2.78%	1.05x	$1.97 Billion
Yunnan Baiyao Group Co Ltd (000538)	$3.19 Billion	14.61%	0.55x	$13.23 Billion
Hainan Haiyao Co Ltd (000566)	$1.49 Billion	5.19%	0.85x	$1.11 Billion
Tus Pharmaceutical Group Co Ltd (000590)	$231.22 Million	-38.13%	1.23x	$302.41 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$1.75 Billion	0.46%	2.42x	$956.43 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$1.35 Billion	7.34%	0.44x	$3.16 Billion

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic

Market Cap

$656.14 Million

CN¥4.48 Billion CNY

Market Cap Rank

#10864 Global

#2970 in China

Share Price

CN¥2.25

Change (1 day)

-0.44%

52-Week Range

CN¥1.72 - CN¥3.21

All Time High

CN¥9.91